Tramadol Hydrochloride
Product Images NDC 63629-4899

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 63629-4899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636294899)

Label Image (Lbl636294899)
Packaging label for Tramadol HCl 50mg (CIV) tablets by Bryant Ranch Prepack in Burbank, CA. The label indicates a comparison to Ultram 50mg (CIV) tablets and shows a quantity of 30 tablets. Storage instructions specify room temperature between 20-25°C (68-77°F). The label includes warnings about drowsiness and keeping the drug out of reach of children. The NDC number 63629-4899-91 is displayed along with a barcode and lot number 1523487.*
FDA Label Image

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)

7bb9a2e6-figure-01 (Tramadol HCl Tablets Usp 1)
Chemical structure diagram of Tramadol Hydrochloride showing its molecular arrangement with key functional groups and hydrochloride component.*
FDA Label Image

Figure 1 (Tramadol HCl Tablets Usp 2)

Figure 1 (Tramadol HCl Tablets Usp 2)
A line graph showing plasma concentration (ng/mL) over time (hours) for Tramadol and its metabolite M1, comparing multiple dose and single dose administration. The graph includes four curves representing Tramadol multiple dose, Tramadol single dose, M1 multiple dose, and M1 single dose, with concentration decreasing over a 48-hour period.*
FDA Label Image

Figure 2 (Tramadol HCl Tablets Usp 3)

Figure 2 (Tramadol HCl Tablets Usp 3)
A line chart titled 'Protocol CAPSS-047 Time to Discontinuation Due to Nausea/Vomiting' showing the percentage of participants discontinuing over 25 days in a double-blind study. Two lines compare discontinuation rates for 10-day versus 16-day dosing to 200 mg/day, with the 10-day group showing a higher percent discontinuing over time than the 16-day group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.